Stay updated on Clinical Trial: Nivolumab in HCC with Electroporation
Sign up to get notified when there's something new on the Clinical Trial: Nivolumab in HCC with Electroporation page.

Latest updates to the Clinical Trial: Nivolumab in HCC with Electroporation page
- CheckyesterdayChange DetectedThe footer revision identifier changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check8 days agoChange DetectedThe site footer’s revision label changed from v3.7.0 to v3.7.1. The page still displays a 403 error instead of the study record.SummaryDifference0.2%

- Check15 days agoChange DetectedThe study record page shows a 403 Forbidden message and a Home link in place of the trial details.SummaryDifference0.5%

- Check29 days agoChange DetectedThe page now shows a 403 Forbidden error instead of the study record, indicating access restrictions rather than new or updated study details. The header and footer remain visible, but no study information is presented.SummaryDifference19%

- Check50 days agoChange DetectedThe page now shows a new Revision: v3.6.6, replacing the previous v3.6.5, indicating a minor update to the page or site infrastructure.SummaryDifference0.1%

- Check71 days agoChange DetectedThe revision label was updated from v3.6.4 to v3.6.5, indicating a deployment update. The change does not modify the displayed study information.SummaryDifference0.1%

Stay in the know with updates to Clinical Trial: Nivolumab in HCC with Electroporation
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Nivolumab in HCC with Electroporation page.